People who use drugs in Europe are facing new health risks as drug markets evolve rapidly and become more complex. This warning comes from the European Union Drugs Agency (EUDA) in its European Drug Report 2026: Trends and Developments, released today (1).
Based on data from 29 countries (EU-27, Norway and Türkiye), the annual review highlights risks to public health posed by the wide availability and use of an increasingly diverse range of substances, often of high potency or purity. New cannabis products continue to appear, while the variety of opioids and stimulants sold is on the rise.…
Čtěte více
Today, the European Union Drugs Agency (EUDA) launches a public consultation to help shape its forthcoming Strategy 2030. The consultation forms part of a broader stakeholder engagement process supporting the development of the strategy, which will define the agency’s strategic priorities for the coming years.
The consultation seeks views on the future role of the agency, the…
Čtěte více
The latest patterns of injecting drug use in a selection of European cities are presented today in a new analysis from the European Union Drugs Agency (EUDA). The findings are from the agency’s ESCAPE project (1), which investigates the substances used by people who inject drugs (PWID) by chemically analysing the content of used syringes.
An estimated 500 000 people inject drugs in the EU, and they face elevated risks of overdose and infectious diseases. Reliable information on the substances being injected is essential to guide prevention strategies and the provision of harm reduction…
Čtěte více
